## **Core Concept**
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect various parts of the body, including the skin, joints, kidneys, brain, and other organs. It is characterized by periods of flares and remission, with a wide range of clinical manifestations. The diagnosis of SLE often involves a combination of clinical findings, laboratory tests, and the presence of specific autoantibodies.

## **Why the Correct Answer is Right**
The correct answer, . , refers to the presence of **antinuclear antibodies (ANA)**, which is a hallmark of SLE. ANA are a type of autoantibody that targets the body's own nuclear material and are found in approximately 98% of patients with SLE. The presence of ANA is one of the diagnostic criteria for SLE, as outlined by the American College of Rheumatology.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because while skin manifestations, such as the characteristic butterfly-shaped rash across the cheeks, are common in SLE, they are not exclusive to the disease and can be seen in other conditions as well.
- **Option B:** - This option is incorrect because, although joint pain and swelling are frequent complaints in SLE patients, they are not unique to SLE and can be found in many other rheumatic diseases, such as rheumatoid arthritis.
- **Option C:** - This option is incorrect because, while kidney involvement (lupus nephritis) is a serious complication of SLE, it does not occur in all patients and is not the most characteristic feature of the disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for SLE is that a **negative ANA result** essentially rules out SLE, making it a valuable screening tool. However, a positive ANA result can be seen in a variety of other conditions, including rheumatoid arthritis, scleroderma, and Sjögren's syndrome, as well as in healthy individuals, especially the elderly.

## **Correct Answer:** . Antinuclear antibodies (ANA)